aid: alpha9
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/alpha9.png
name: Alpha-9 Oncology
description: Alpha-9 Oncology is a clinical-stage radiopharmaceutical company developing
  targeted radioligand therapies and imaging agents to treat solid and hematologic
  cancers with high precision. Founded in 2019 and backed by Lightspeed Venture Partners,
  the company engineers each molecule — binder, linker, chelator, and radioisotope —
  through a bespoke, iterative optimization process, and is advancing a pipeline that
  includes the A9-3202 imaging agent and the Actinium-225-based therapeutic A9-3408
  into clinical trials. Alpha-9 is a therapeutics company with no public developer API,
  developer portal, or SDKs; it was surfaced in the API Evangelist network as a
  venture-portfolio lead from Lightspeed Venture Partners.
url: https://raw.githubusercontent.com/api-evangelist/alpha9/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- lightspeed-venture-partners
x-tier: stub
x-tier-reason: no-api-surface-biotech
x-industry: healthcare-biotechnology
x-enrichment-note: 'Enrichment run 2026-07-17 confirmed Alpha-9 Oncology is a clinical-stage
  biotech (radiopharmaceuticals). No developer API, OpenAPI, SDKs, MCP, or technical
  surface exists. Only real, published identity/link properties were captured; no API
  artifacts were fabricated.'
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-17'
tags:
- Company
- Biotechnology
- Oncology
- Radiopharmaceuticals
- Pharmaceuticals
- Healthcare
- Clinical-Stage
- Precision Medicine
apis: []
common:
- type: Website
  url: https://a9oncology.com
- type: Support
  url: https://www.a9oncology.com/contact/
- type: Blog
  url: https://www.a9oncology.com/news/
- type: PrivacyPolicy
  url: https://www.a9oncology.com/privacy-policy/
- type: TermsOfService
  url: https://www.a9oncology.com/terms-of-use/
- type: LinkedIn
  url: https://www.linkedin.com/company/alpha9tx
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence